Combined 4-1BB and CD28 Costimulation Could Unleash Lymphocytes from Immunosuppression Induced by Adipose Derived Stem Cell Soluble Products

REFERENCES

• Abumaree, M., Al Jumah, M., Pace, R. A., (2011). Immunosuppressive Properties of Mesenchymal Stem Cells. Stem Cell Rev. Sep 3;8(2):375–392.
   Google Scholar
• Auletta, J. J., Deans, R. J., Bartholomew, A. M. (2012). Emerging roles for multipotent, bone marrow-derived stromal cells in host defense. Blood Feb 23;119(8):1801–1809.
   PubMedGoogle Scholar
• Bartholomew, A., Sturgeon, C., Siatskas, M., (2002). Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. Jan;30(1):42–48.
   PubMed Web of Science ®Google Scholar
• Bassi, E. J., De Almeida, D. C., Moraes-Vieira, P. M., (2011). Exploring the role of soluble factors associated with immune regulatory properties of mesenchymal stem Cells. Stem Cell Rev. Sep 1;8(2):329–342.
   Google Scholar
• Batten, P., Sarathchandra, P., Antoniw, J. W., (2006). Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves. Tissue Eng. Aug;12(8):2263–2273.
   PubMedGoogle Scholar
• Benvenuto, F., Ferrari, S., Gerdoni, E., (2007). Human mesenchymal stem cells promote survival of T cells in a quiescent state. Stem Cells. Jul;25(7):1753–1760.
   PubMedGoogle Scholar
• Cappellesso-Fleury, S., Puissant-Lubrano, B., Apoil, P. A., (2010). Human fibroblasts share immunosuppressive properties with bone marrow mesenchymal stem cells. J. Clin. Immunol. Jul;30(4):607–619.
   PubMed Web of Science ®Google Scholar
• Chen, X., McClurg, A., Zhou, G. Q., (2007). Chondrogenic differentiation alters the immunosuppressive property of bone marrow-derived mesenchymal stem cells, and the effect is partially due to the upregulated expression of B7 molecules. Stem Cells. Feb;25(2):364–70.
   PubMedGoogle Scholar
• Chiesa, S., Morbelli, S., Morando, S., (2011). Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells. Proc. Natl. Acad. Sci. USA Oct 18;108(42):17384–17389.
   PubMed Web of Science ®Google Scholar
• Ciapetti, G., Granchi, D., Baldini, N. (2012). The Combined Use of Mesenchymal Stromal Cells and Scaffolds for Bone Repair. Curr. Pharm. Des. Jan 19;18(13):1796–1820.
   PubMedGoogle Scholar
• Constantin, G., Marconi, S., Rossi, B., (2009). Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells Oct;27(10):2624–2635.
   PubMed Web of Science ®Google Scholar
• Croitoru-Lamoury, J., Lamoury, F. M., Caristo, M., (2011). Interferon-gamma regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO). PLoS One 6(2):e14698.
   PubMedGoogle Scholar
• Crop, M. J., Baan, C. C., Korevaar, S. S., (2010). Human adipose tissue-derived mesenchymal stem cells induce explosive T-cell proliferation. Stem Cells Dev. Dec;19(12):1843–1853.
   PubMedGoogle Scholar
• Ding, Y., Xu, D., Feng, G., (2009). Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9. Diabetes Aug;58(8):1797–1806.
   PubMed Web of Science ®Google Scholar
• Duffy, M. M., Ritter, T., Ceredig, R., (2011). Mesenchymal stem cell effects on T-cell effector pathways. Stem Cell Res. Ther. 2(4):34.
   PubMed Web of Science ®Google Scholar
• Friedenstein, A. J., Deriglasova, U. F., Kulagina, N. N., (1974). Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp. Hematol. 2(2):83–92.
   PubMed Web of Science ®Google Scholar
• Friedenstein, A. J., Piatetzky-Shapiro, I. I., Petrakova, K. V.(1996). Osteogenesis in transplants of bone marrow cells. J. Embryol. Exper. Morphol. 1996;16(3):381–390.
   Google Scholar
• Ghannam, S., Bouffi, C., Djouad, F., (2010). Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Stem Cell Res. Ther. 1(1):2.
   PubMed Web of Science ®Google Scholar
• Giuliani, M., Fleury, M., Vernochet, A., (2011). Long-lasting inhibitory effects of fetal liver mesenchymal stem cells on T-lymphocyte proliferation. PLoS One 6(5):e19988.
   PubMedGoogle Scholar
• Glennie, S., Soeiro, I., Dyson, P. J., (2005). Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood Apr 1;105(7):2821–2827.
   PubMed Web of Science ®Google Scholar
• Habib-Agahi, M., Jaberipour, M., Searle, P. F. (2009). 4-1BBL costimulation retrieves CD28 expression in activated T cells. Cell Immunol. 256(1–2):39–46.
   PubMedGoogle Scholar
• Habib-Agahi, M., Phan, T. T., Searle, P. F. (2007). Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells. Int. Immunol. Dec;19(12):1383–1394.
   PubMed Web of Science ®Google Scholar
• Klyushnenkova, E., Mosca, J. D., Zernetkina, V., (2005). T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J. Biomed. Sci. 12(1):47–57.
   PubMed Web of Science ®Google Scholar
• Majumdar, M. K., Thiede, M. A., Mosca, J. D., (1998). Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J. Cell Physiol. Jul;176(1):57–66.
   PubMed Web of Science ®Google Scholar
• Meisel, R., Zibert, A., Laryea, M., (2004). Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood Jun 15;103(12):4619–4621.
   PubMed Web of Science ®Google Scholar
• Mousavi Niri, N., Jaberipour, M., Razmkhah, M., (2009). Mesenchymal stem cells do not suppress lymphoblastic leukemic cell line proliferation. Iran J. Immunol. Dec;6(4):186–194.
   PubMedGoogle Scholar
• Najar, M., Raicevic, G., Boufker, H. I. (2010). Adipose-tissue-derived and Wharton’s jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor. Tissue Eng. Pt. A Nov;16(11):3537–3546.
   PubMedGoogle Scholar
• Ohishi, M., Schipani, E. (2010). Bone marrow mesenchymal stem cells. J. Cell Biochem. Feb 1;109(2):277–282.
   PubMed Web of Science ®Google Scholar
• Rasmusson, I., Ringden, O., Sundberg, B., (2005). Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp. Cell Res. Apr 15;305(1):33–41.
   PubMed Web of Science ®Google Scholar
• Rasmusson, I., Uhlin, M., Le Blanc, K., (2007). Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes. J. Leukoc. Biol. Oct;82(4):887–893.
   PubMed Web of Science ®Google Scholar
• Razmkhah, M., Jaberipour, M., Erfani, N., (2011). Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-beta1 and upregulate expression of regulatory molecules on T cells: do they protect breast cancer cells from the immune response? Cell Immunol. 266(2):116–122.
   PubMedGoogle Scholar
• Ringden, O., Le Blanc, K. (2011). Mesenchymal stem cells for treatment of acute and chronic graft-versus-host disease, tissue toxicity and hemorrhages. Best Pract. Res. Clin. Haematol. Mar;24(1):65–72.
   PubMed Web of Science ®Google Scholar
• Roemeling-Van Rhijn, M., Weimar, W., Hoogduijn, M. J. (2012). Mesenchymal stem cells: application for solid-organ transplantation. Curr. Opin. Organ Transplant. Feb;17(1):55–62.
   PubMedGoogle Scholar
• Shi, D., Liao, L., Zhang, B., (2011). Human adipose tissue-derived mesenchymal stem cells facilitate the immunosuppressive effect of cyclosporin A on T lymphocytes through Jagged-1-mediated inhibition of NF-kappaB signaling. Exp. Hematol. Feb;39(2):214–224 e1.
   PubMedGoogle Scholar
• Talens-Visconti, R., Bonora, A., Jover, R., (2006). Hepatogenic differentiation of human mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells. World J. Gastroenterol. Sep 28;12(36):5834–5845.
   PubMed Web of Science ®Google Scholar
• Tse, W. T., Pendleton, J. D., Beyer, W. M., (2003). Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation. Feb 15;75(3):389–397.
   PubMed Web of Science ®Google Scholar
• Yang, S. H., Park, M. J., Yoon, I. H., (2009). Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10. Exp. Mol. Med. May 31;41(5):315–24.
   PubMedGoogle Scholar
• Yoo, K. H., Jang, I. K., Lee, M. W., (2009). Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol. 259(2):150–156.
   PubMed Web of Science ®Google Scholar
• Zhong, X. S., Matsushita, M., Plotkin, J., (2010). Chimeric antigen receptors combining 4-1BB and CD28 signaling domains augment PI3kinase/AKT/Bcl-XL activation and CD8+ T cell-mediated tumor eradication. Mol. Ther. Feb;18(2):413–420.
   PubMed Web of Science ®Google Scholar